跳至主要内容
临床试验/IRCT138901213678N1
IRCT138901213678N1已完成2 期

A double blind clinical trial for study of preventive effect of selenium in cisplatin induced nephrotoxicity

Research deputy of Ahvaz Jundishapur university of medical sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 149 years(—)
性别
All

入选标准

  • Patients who were referred to Shafa hospital for chemotherapy with Cisplatin1388-1389
  • Exclusion criteria:1) serum Creatinine more than 1.5mg/dl in man and more than 1.4mg/dl
  • 2) Use of other nephrotoxic drug such as NSAID, ACEI, Aminoglycoside
  • at 2 weeks later
  • 4) Pancytopenia
  • 5) Patient who refused Selenium

排除标准

  • 未提供

研究者

发起方
Research deputy of Ahvaz Jundishapur university of medical sciences

相似试验

Study of preventive effect of selenium in cisplatin... | 临床试验